CBLN1 and Behcet disease: As already described in Section 3.1 and Section 3.2, Tkachev et al. (2023) suggested that SCH- and BD-associated changes in plasma lipidomic profiles are largely shared [50], and one of the main novel findings of the study was that alterations in Cer levels were characteristic for both BD and SCH patients.